This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Urigen Pharmaceuticals, Inc., Vaneltix Pharma, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: Lowell C Parsons: Innovator in Local Anesthetic Stability
Introduction
Lowell C Parsons is a notable inventor based in Henderson, NV (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of local anesthetics. With a total of 2 patents, his work focuses on improving the stability of medical compositions.
Latest Patents
One of his latest patents is an article of manufacture comprising a local anesthetic, buffer, and glycosaminoglycan in a syringe with improved stability. This invention includes a composition that features a glycosaminoglycan, a local anesthetic, and a buffer, all packaged in a syringe or vial made from either glass or a specific type of plastic. The selected plastics include cyclic olefin polymer, cyclic olefin copolymer, or high-density non-nucleated polypropylene. This innovative composition has shown unexpectedly improved stability during storage. It can be formulated for the treatment of urinary tract diseases or conditions, such as interstitial cystitis, also known as bladder pain syndrome or hypersensitive bladder syndrome.
Career Highlights
Throughout his career, Lowell has worked with several companies, including Urigen Pharmaceuticals, Inc. and Vaneltix Pharma, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Some of his notable coworkers include Dan Vickery and Christopher Meenan. Their collaborative efforts have likely played a role in advancing the projects they have worked on together.
Conclusion
Lowell C Parsons is a distinguished inventor whose work in local anesthetic formulations has the potential to significantly impact medical treatments. His innovative approaches to stability in pharmaceutical compositions highlight his contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile